fc ph365 info

Albertsons’ $24.6 billion merger with Kroger blocked by judgeTensions flared toward the end of the Dallas Cowboys' 41-7 blowout loss to the Philadelphia Eagles on Sunday, resulting in the ejections of multiple players. Cowboys wide receiver Jalen Brooks and cornerback Troy Pride Jr. got into a scuffle with Eagles safety Sydney Brown that led to them being tossed from the game late in the fourth quarter: This article will be updated soon to provide more information and analysis. For more from Bleacher Report on this topic and from around the sports world, check out our B/R app , homepage and social feeds—including Twitter , Instagram , Facebook and TikTok .

Review of national energy stance urgedThe standard Lorem Ipsum passage, used since the 1500s "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" To keep reading, please log in to your account, create a free account, or simply fill out the form below.

None

Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market opportunity Focusing on advancing radiotherapeutic assets including alpha- and Auger-emitting radioconjugates into Phase 1 solid tumor studies FLORHAM PARK, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces a strategic update on its clinical development programs for its proprietary phospholipid ether drug conjugate platform that delivers a broad array of therapeutic modalities to target cancers. Due to recent communications with the U.S. Food and Drug Administration (FDA, or the Agency) regarding a confirmatory study to support accelerated approval and the regulatory submission for iopofosine I 131, the Company has decided to pursue strategic options for the further development and commercialization of this product candidate. The CLOVER-WaM study was conducted in accordance with earlier FDA communications from an end of Phase 2 meeting and from a meeting in early 2024, during which the Company was informed that positive results for major response rate (MRR) as the primary endpoint could be acceptable to support accelerated approval of iopofosine I 131 as a treatment for Waldenstrom’s macroglobulinemia (WM). Based upon a recent Type-C meeting with the FDA, the Company now believes that a submission seeking accelerated approval would need to be based on the MRR data from CLOVER-WaM and enrollment in a randomized, controlled confirmatory study that is designed to generate data on progression-free survival (PFS). “While iopofosine I 131’s positive WM data along with the high unmet medical need for these patients support further investment, we have determined that such a program may best be brought to market by a larger organization with greater resources. Importantly, partnering or divesting this program supports our commitment to providing this potentially life-saving drug to the patients who need it as quickly as possible,” stated James Caruso, president and CEO of Cellectar. “We believe iopofosine I 131 represents a compelling opportunity as it has shown strong efficacy and good tolerability based on our clinical studies. Moreover, the commercial work we conducted demonstrates iopofosine I 131’s substantial market opportunity based upon the product profile, which includes off-the-shelf global distribution, orphan pricing and existing unmet medical need.” Cellectar remains confident in the potential of its phospholipid ether drug conjugate platform and the targeted radiotherapies in its development pipeline. Iopofosine I 131’s clinical success validates the platform’s ability to target cancers and Cellectar will leverage its experience to focus on the development of its earlier clinical programs. Specifically, Cellectar will focus on those assets it believes have the highest therapeutic potential and opportunity for value creation. As highlighted by recent acquisitions and collaborations within the radiopharmaceutical sector, precision isotopes like alpha- and Auger-emitters have emerged as the leading therapeutics of interest. Consequently, the Company will now focus its resources on targeting solid tumors by advancing CLR 121225, its actinium-225 based program, and CLR 121125, its iodine-125 Auger-emitting program into the clinic. Cellectar expects to file Investigational New Drug applications in the first half of 2025 for both CLR-121225 and CLR-121125, which will allow the initiation of Phase 1 clinical studies in solid tumor cancers. Both programs have demonstrated robust in vivo activity, tolerability, excellent targeting and uptake in preclinical solid tumor models. The Company believes this approach will provide an expedited timeframe to achieve safety and proof-of-concept data in patients. The Company’s strategic reprioritization will impact all departments and result in an immediate reduction in headcount of approximately 60%, which should be complete by the end of the fourth quarter 2024. The Company anticipates that the implementation of the restructuring will extend its cash runway into the third quarter of 2025. “We are being methodical in our efforts to reorganize the company with the goal of conserving cash while maintaining the flexibility to execute immediate priorities and build for long-term growth and value creation. This reorganization is difficult but necessary for the future growth potential of Cellectar,” said Mr. Caruso. “I want to extend my deepest gratitude to our departing employees for their significant contributions to our work and their dedication to making a difference in the lives of patients.” About Cellectar Biosciences, Inc. Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery and development of proprietary drugs for the treatment of cancer, independently and through research and development collaborations. The company’s core objective is to leverage its proprietary Phospholipid Drug Conjugate TM (PDC) delivery platform to develop the next-generation of cancer cell-targeting treatments, delivering improved efficacy and better safety as a result of fewer off-target effects. The company’s product pipeline includes lead asset, iopofosine I 131, a small-molecule PDC designed to provide targeted delivery of iodine-131 (radioisotope), CLR 121225, an actinium-225 based program being targeted to several solid tumors with significant unmet need, such as pancreatic cancer, CLR 121125, an iodine-125 Auger-emitting program targeted in other solid tumors, such as triple negative breast, lung and colorectal, proprietary preclinical PDC chemotherapeutic programs and multiple partnered PDC assets. In addition, iopofosine I 131 is under evaluation in Phase 2b studies for relapsed or refractory multiple myeloma (MM) and central nervous system (CNS) lymphoma, alongside the CLOVER-2 Phase 1b study, targeting pediatric patients with high-grade gliomas, for which Cellectar is eligible to receive a Pediatric Review Voucher from the FDA upon approval. The FDA has also granted iopofosine I 131 Orphan Drug and Fast Track Designations for various cancer indications. New data from the CLOVER-WaM Phase 2 clinical trial were recently presented in an oral presentation at the 66th American Society of Hematology Annual Meeting and Exposition (ASH 2024). For more information, please visit www.cellectar.com or join the conversation by liking and following us on the company’s social media channels: Twitter, LinkedIn, and Facebook. Forward-Looking Statement Disclaimer This news release contains forward-looking statements. You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or their negatives or cognates. These statements are only estimates and predictions and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to raise additional capital, uncertainties related to the disruptions at our sole source supplier of iopofosine, the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, patient enrollment and the completion of clinical studies, the FDA review process and other government regulation, our ability to obtain regulatory exclusivities, the availability of priority review vouchers, our ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement. A complete description of risks and uncertainties related to our business is contained in our periodic reports filed with the Securities and Exchange Commission including our Form 10-K/A for the year ended December 31, 2023, and our Form 10-Q for the quarter ended September 30, 2024. These forward-looking statements are made only as of the date hereof, and we disclaim any obligation to update any such forward-looking statements. Contacts MEDIA: Christy Maginn Bliss Bio Health 703-297-7194 cmaginn@blissbiohealth.com INVESTORS: Anne Marie Fields Precision AQ 212-362-1200 annemarie.fields@precisionaq.com

RECAP: Asian equities fell yesterday as a lack of details from a Chinese economic conference disappointed some traders and risk appetite weakened ahead of next week's US Federal Reserve interest rate meeting. The SET index moved in a range of 1,429.68 and 1,456.92 points this week, before closing yesterday at 1,431.67, down 1.4% from the previous week, with daily turnover averaging 39.08 billion baht. Retail investors were net buyers of 3.1 billion baht, followed by institutional investors at 2.4 billion. Foreign investors were net sellers of 5.4 billion baht, followed by brokerage firms at 83.26 million. NEWSMAKERS: The European Central Bank on Thursday made its fourth interest rate cut of 2024, bringing its deposit facility rate to 3% while lowering its inflation forecast. The euro zone economy is "losing momentum" as manufacturing has contracted and growth in services slowed, ECB president Christine Lagarde cautioned. BlackRock, the world's largest fund manager by assets, has recommended that investors "with suitable governance and risk tolerance" consider allocating as much as 2% of their portfolio to bitcoin. Tesla CEO Elon Musk's net worth crossed $400 billion on Thursday, the Forbes real-time billionaires list showed, boosted by a nearly 71% surge in the automaker's shares this year and the soaring valuation of his rocket company SpaceX. The global airline industry stands to earn $36.6 billion in net profit in 2025, up 16% from this year, driven by a record 5.2 billion passengers taking to the skies, the International Air Transport Association said on Wednesday. It expects industry revenue to exceed $1 trillion for the first time in 2025. China's anti-monopoly regulator says it is investigating potential antitrust violations by Nvidia, the US company that makes a vast majority of the computer chips that power artificial intelligence systems, as the Washington-Beijing chip war intensifies. US consumer inflation rose in line with expectations to 2.7% year-on-year in November from 2.6% in October. The producer price index rose 0.4% from a month earlier. The US jobs report showed 227,000 non-farm positions added in November, with unemployment at 4.2%, supporting expectations of another Fed interest rate cut next week, with cuts continuing until the third quarter of 2025. The Bank of Canada slashed its key policy rate by 50 basis points to 3.25% on Wednesday but indicated further cuts would be more gradual as it seeks to support growth. The Biden administration is reportedly weighing harsher measures against the lucrative Russian oil trade that appears to have been largely immune to US sanctions. China's exports and imports in November both missed expectations, official data showed, as consumer demand remains sluggish and tariff threats loom. Imports declined 3.9%, the sharpest fall since September 2023, as exports rose 6.7% in dollar terms, down from 12.7% growth in October. The Indonesian rupiah dropped past the key psychological level of 16,000 per dollar yesterday, escalating pressure on the central bank after it already undertook what it called "bold" moves to support the currency. The German online fashion retailer Zalando plans to acquire local rival About You for 1.1 billion euros to create a European platform that can better compete with Chinese e-commerce giants. China's central bank resumed purchasing gold for its reserves in November after a six-month pause. The return to gold buying may help stimulate demand among Chinese investors. Prime Minister Paetongtarn Shinawatra announced new populist measures on Thursday to boost the sluggish economy, including soft loans for community businesses, funds for villages, cheap housing for Bangkok low-income workers, energy price cuts and a flat rate for urban rail travel. The national wage committee has postponed until Dec 23 a decision on the minimum wage for 2025. But members have indicated that a flat rate of 400 baht a day nationwide, as promised by the government, is unrealistic. The cabinet on Wednesday approved more debt-relief measures covering 1.9 million debtors with 890 billion baht worth of loans. The loans, which were taken to purchase houses and automobiles and finance small businesses, will be eligible for interest suspension for three years. The cabinet has approved draft legislation to impose a global minimum corporate tax of 15% on multinational enterprises in line with OECD guidelines. The tax will apply to multinationals with annual global turnover of more than €750 million. Prime Minister Paetongtarn dismissed talk of the value-added tax rate rising to 15% from 7%. She said the idea was simply one of many topics for discussion as the finance ministry looks to rebalance the tax system. Consumer confidence rose for a second consecutive month to 56.9 in November, from 56.0 in the previous month, bolstered by government economic measures and tourism, the University of the Thai Chamber of Commerce said. The SET has announced changes to the FTSE SET Index Series, effective this month, with Minor International (MINT) being included in the Large Cap Index. Cal-Comp Electronics (Thailand) (CCET) and Energy Absolute (EA) will be added to the Mid Cap Index. The Public Debt Management Office plans to issue 100 billion baht in sustainable bonds next year to fund the government deficit. In November it issued 30 billion baht in sustainability-linked bonds paying 2.7%. The Ministry of Finance is allocating 20 billion baht to purchase additional shares in Thai Airways International Plc on Dec 12, raising the ministry's stake in the national carrier to 40% from 30%. COMING UP: On Monday, China updates unemployment data. On Tuesday, the US reports retail sales and industrial production, while Japan releases November trade figures. The UK and the euro zone update inflation on Wednesday, while the Federal Reserve and Bank of Japan will announce interest rate decisions. On Thursday, the Bank of England holds a rate meeting, and the US releases revised quarterly GDP and existing home sales. Locally, the Exim Bank will hold a press conference on Monday, while the Federation of Thai Capital Market Organizations will host a ThaiESG Fund seminar. On Wednesday the Bank of Thailand has its last rate meeting of 2024. STOCKS TO WATCH: InnovestX Securities recommends stocks likely to benefit from economic stimulus and household debt relief measures. Recommended commerce plays are CPALL, CPAXT, CRC, HMPRO and TNP, while tourism stocks include AWC, AOT and MINT. Stocks expected to report growth in Q4 profit and outperform the market include GULF, OSP, AMATA, AU, TIDLOR and BCP. Asia Plus Securities says investors could consider speculative plays on candidates to enter and exit SET50 in the first half of 2025, such as CCET, SAWAD, COM7 and BANPU, as well as firms expecting to outperform the market for the rest of 2024. TECHNICAL VIEW: InnovestX Securities sees support at 1,430 points and resistance at 1,460. Trinity Securities sees support at 1,430 and resistance at 1,470.

The man charged in the killing of the CEO of UnitedHealthcare reported in online writings over a period of years that he had been navigating a series of life-altering health problems. In posts on a Reddit account, the man, Luigi Mangione , said back pain that had once been a minor issue in his life grew more extreme in 2022 after he went surfing, then grew worse again a few weeks later when he slipped on a piece of paper. He reported persistent problems, including pain when he sat down, twitching leg muscles, and numbness in his groin and bladder. Suspect Luigi Mangione yells as he is taken into the Blair County Courthouse in Hollidaysburg, Pennyslvania. Credit: AP He shared details that friends have corroborated, writing that he had a spinal fusion surgery in July 2023. He wrote that within days he did not need pain meds and could sit, stand and walk just fine. “The surgery wasn’t nearly as scary as I made it out to be in my head, and I knew it was the right decision within a week,” he wrote in one Reddit post. He went on to encourage others to consider such surgery, pointing to athletes who had done so. An X-ray that he posted on another social media account showed a spinal fusion. The back pain was not his only struggle. He wrote at times about “brain fog” that had worsened during his college years, making studying more difficult. Doctors could not seem to figure out what was happening, he reported. “It’s absolutely brutal to have such a life-halting issue,” he wrote. He also posted on a page for people dealing with irritable bowel syndrome, saying that he had undergone some testing for the condition. He said the testing had been covered by Blue Cross Blue Shield — his only reference in the Reddit writings to insurance coverage. After the back surgery, he returned to Hawaii, where he had previously been living, but by the spring of this year, he had ceased communications with most friends and family members. His family reached out to his friends in recent months in hopes of finding him. Arraignment photo of Luigi Mangione, a suspect in the fatal shooting of UnitedHealthcare CEO Brian Thompson. Credit: AP The suspect’s comment history on Reddit gives other clues to his personal life and pursuits. He was an active commenter in the OneBag subreddit, a community that “promotes urban travel with the philosophy of carrying less” and focuses on different types of backpacks and travel gear. Photos released by the New York Police Department of the assailant in the UnitedHealthcare shooting showed what its maker identified as a backpack by Peak Design, a brand that was widely discussed in the OneBag subreddit. The suspect also posted to the Magfest subreddit, a community dedicated to a gaming subculture and festival held annually in Maryland, where he grew up. Sarah Nehemiah, a friend during his time in Hawaii, described him as an avid gamer and Pokémon enthusiast. He posted enthusiastically to the Pokémon Go subreddit, a forum dedicated to the popular mobile augmented reality game in which users catch virtual Pokémon using their mobile phones. Police have charged Luigi Mangione with the murder of Brian Thompson. Credit: Facebook Gaming has long been a part of the suspect’s life. He spent much of his childhood creating games and later went into the tech and gaming industry, working as an intern at the company that created the enormously popular Civilization game franchise. The Reddit account has since been deleted by the company, but archived versions of the posts were reviewed by The New York Times . A Reddit spokesperson said its policy was to suspend accounts that may potentially be related to suspects in high-profile criminal investigations. A 2016 photo of Luigi Mangione taken from his social media accounts. Credit: Facebook Tech companies typically suspend accounts in such cases to avoid impersonation. On Monday, Meta suspended the suspect’s accounts on Facebook and Instagram. And GoodReads, a site dedicated to chronicling a person’s reading activities, suspended his account the same day. This article originally appeared in The New York Times . Get a note directly from our foreign correspondents on what’s making headlines around the world. Sign up for the weekly What in the World newsletter here .KALAMAZOO, Mich. (AP) — Zahir Abdus-Salaam ran for a touchdown and caught another as Western Michigan defeated Eastern Michigan 26-18 on Saturday to become bowl eligible, snapping a three-game losing streak. Abdus-Salaam scored on a 22-yard run for a 23-8 lead in the third quarter and he celebrated by jumping into a snowbank bordering the end zone. The Broncos (6-6, 5-3 Mid-American Conference) blocked a punt for safety that started a run of 16 points in under four minutes. Abdus-Salaam scored on a 31-yard screen pass then Joey Pope recovered a fumble on the ensuing kickoff to set up Jalen Buckley's 15-yard TD run with 19 seconds before the half ended. Eastern Michigan's Delmert Mimms II scored two third-quarter touchdowns. The teams exchanged field goals for the only fourth-quarter scoring. The Eagles got the ball back with 2:18 remaining but on their first play Bilhal Kone intercepted a tipped pass. Eastern Michigan (5-7, 2-6) lost its last five games. Abdus-Salaam rushed for 135 yards and Buckley 103 on 19 carries apiece. Hayden Wolff threw for 126 yards and a score. Abdus-Salaam had 40 yards receiving. Mimms rushed for 127 yards on 18 carries. Cole Snyder was only 7 of 22 for 91 yards passing. AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football . Sign up for the AP’s college football newsletter: https://apnews.com/cfbtop25

Hexafluorobutadiene Gas Market Set for Exceptional Growth from 2024 to 2032 12-29-2024 06:57 PM CET | Business, Economy, Finances, Banking & Insurance Press release from: Prudent Markets Hexafluorobutadiene Gas Market The Hexafluorobutadiene Gas Market 2024-2023 report provides a comprehensive analysis of Types (3N, 4N, 4N5), Application (Electronics Etching, Chemical Synthesis, Others), Analysis of Industry Trends, Growth, and Opportunities, R&D landscape, Data security and privacy concerns Risk Analysis, Pipeline Products, Assumptions, Research Timelines, Secondary Research and Primary Research, Key Insights from Industry Experts, Regional Outlook and Forecast, 2024-2032. Major Players of Hexafluorobutadiene Gas Market are: Kanto Denka Kogyo, Showa Denko, Foosung Co., Ltd., Linde Gas, Taiyo Nippon Sanso, Air Liquide, Versum Materials (Merck), Solvay, SK Materials, GrandiT Co., Ltd., Zhejiang Britech, Zhongshan Photoelectric Materials, Beijing Yuji Science & Technology Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/9169767/ Hexafluorobutadiene is an organofluorine compound with the formula (CF2=CF)2. A colorless gas, it has attracted attention as an etchant in microelectronics. It is the perfluoroanalogue of butadiene. It can be prepared by coupling of C2 compounds such as from chlorotrifluoroethylene or bromotrifluoroethylene. Routes from C4 species have also been demonstrated. This report provides a deep insight into the global Hexafluorobutadiene Gas market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hexafluorobutadiene Gas Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. Segmentation of Hexafluorobutadiene Gas Market- By Type 3N, 4N, 4N5 By Application Electronics Etching, Chemical Synthesis, Others Geographic Segmentation -North America (USA, Canada, Mexico) -Europe (Germany, UK, France, Russia, Italy, Rest of Europe) -Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) -South America (Brazil, Argentina, Columbia, Rest of South America) -The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs. Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/9169767/ Key Benefits of the Report: This study presents the analytical depiction of the Hexafluorobutadiene Gas Industry along with the current trends and future estimations to determine the imminent investment pockets. The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Hexafluorobutadiene Gas Market share. The current market is quantitatively analyzed from to highlight the Global Gardening Pots Market growth scenario. Porter's five forces analysis illustrates the potency of buyers & suppliers in the market. The report provides a detailed Hexafluorobutadiene Gas Market analysis based on competitive intensity and how the competition will take shape in coming years. Key poles of the TOC: Chapter 1 Hexafluorobutadiene Gas Market Business Overview Chapter 2 Major Breakdown by Type Chapter 3 Major Application Wise Breakdown (Revenue & Volume) Chapter 4 Manufacture Market Breakdown Chapter 5 Sales & Estimates Market Study Chapter 6 Key Manufacturers Production and Sales Market Comparison Breakdown Chapter 8 Manufacturers, Deals and Closings Market Evaluation & Aggressiveness Chapter 9 Key Companies Breakdown by Overall Market Size & Revenue by Type Chapter 11 Business / Industry Chain (Value & Supply Chain Analysis) Chapter 12 Conclusions & Appendix The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Hexafluorobutadiene Gas Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market. For In-Depth Competitive Analysis - Purchase this Report now at a Complete Table of Contents (Single User License) @ https://www.prudentmarkets.com/checkout/?id=9169767&license_type=su Free Customization on the basis of client requirements on Immediate purchase: 1- Free country-level breakdown of any 5 countries of your interest. 2- Competitive breakdown of segment revenue by market players. Customization of the Report: This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements. In conclusion, the Hexafluorobutadiene Gas Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report. Contact Us: Allan Carter Andheri, Maharashtra, 400102 USA/Canada(Toll Free): 1800-601-6071 Direct Line: +91 83560 50278 Mail: sales@prudentmarkets.com Web: www.prudentmarkets.com About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.

CHARLOTTE, N.C.--(BUSINESS WIRE)--Dec 13, 2024-- Krispy Kreme, Inc. (NASDAQ:DNUT) (“Krispy Kreme” or the “Company”), today announced a quarterly cash dividend of $0.035 per share of common stock, in accordance with the Company’s dividend policy. The dividend was declared today, December 13, 2024, and will be paid on February 5, 2025 to shareholders of record on January 22, 2025. About Krispy Kreme, Inc. Headquartered in Charlotte, N.C., Krispy Kreme is one of the most beloved and well-known sweet treat brands in the world. Our iconic Original Glazed ® doughnut is universally recognized for its hot-off-the-line, melt-in-your-mouth experience. Krispy Kreme operates in 40 countries through its unique network of fresh doughnut shops, partnerships with leading retailers, and a rapidly growing digital business with more than 15,500 fresh points of access. Our purpose of touching and enhancing lives through the joy that is Krispy Kreme guides how we operate every day and is reflected in the love we have for our people, our communities, and the planet. Connect with Krispy Kreme Doughnuts at www.KrispyKreme.com and follow us on social: X , Instagram and Facebook . View source version on businesswire.com : https://www.businesswire.com/news/home/20241211058746/en/ CONTACT: Investor Relations IR@krispykreme.comFinancial Media Edelman Smithfield for Krispy Kreme, Inc. KrispyKremeIR@edelman.com KEYWORD: NORTH CAROLINA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: RETAIL FOOD/BEVERAGE ORGANIC FOOD SOURCE: Krispy Kreme, Inc. Copyright Business Wire 2024. PUB: 12/13/2024 04:30 PM/DISC: 12/13/2024 04:30 PM http://www.businesswire.com/news/home/20241211058746/en

8 Things to Remember About Dexter’s Childhood Before ‘Original Sin’

Manhattan police have obtained a warrant for the arrest of 26-year-old Luigi Nicholas Mangione , suspect in the killing of UnitedHealthcare CEO Brian Thompson . Mangione was arrested at a McDonald’s in Altoona, Pennsylvania, while carrying a gun, mask and writings linking him to the ambush. Mangione is being held without bail in Pennsylvania on charges of possession of an unlicensed firearm, forgery and providing false identification to police. Late Monday, Manhattan prosecutors charged him with five counts, including murder, criminal possession of a weapon and criminal possession of a forged instrument. Here's the latest: White House press secretary Karine Jean-Pierre says “violence to combat any sort of corporate greed is unacceptable” and the White House will “continue to condemn any form of violence.” She declined to comment on the investigation into the Dec. 4 shooting death of UnitedHealthcare CEO Brian Thompson or reports that writings belonging to the suspect, Luigi Mangione, said insurance companies care more about profits than their customers. “This is horrific,” Jean-Pierre said of the fatal shooting of Thompson as he walked in Manhattan. He didn’t appear to say anything as deputies led him to a waiting car outside. “I’m deeply grateful to the men and women of law enforcement whose efforts to solve the horrific murder of Brian Thompson led to the arrest of a suspect in Pennsylvania,” Gov. Hochul said in the statement. “I am coordinating with the District Attorney’s Office and will sign a request for a governor’s warrant to ensure this individual is tried and held accountable. Public safety is my top priority and I’ll do everything in my power to keep the streets of New York safe.” That’s according to a spokesperson for the governor who said Gov. Hochul will do it as soon as possible. Luigi Nicholas Mangione, the suspect in the fatal shooting of a healthcare executive in New York City, apparently was living a charmed life: the grandson of a wealthy real estate developer, valedictorian of his elite Baltimore prep school and with degrees from one of the nation’s top private universities. Friends at an exclusive co-living space at the edge of touristy Waikiki in Hawaii where the 26-year-old Mangione once lived widely considered him a “great guy,” and pictures on his social media accounts show a fit, smiling, handsome young man on beaches and at parties. Now, investigators in New York and Pennsylvania are working to piece together why Mangione may have diverged from this path to make the violent and radical decision to gun down UnitedHealthcare CEO Brian Thompson in a brazen attack on a Manhattan street. The killing sparked widespread discussions about corporate greed, unfairness in the medical insurance industry and even inspired folk-hero sentiment toward his killer. ▶ Read more about Luigi Mangione Peter Weeks, the Blair County district attorney, says he’ll work with New York officials to try to return suspect Luigi Mangione there to face charges. Weeks said the New York charges are “more serious” than in Blair County. “We believe their charges take precedent,” Weeks said, promising to do what’s needed to accommodate New York’s prosecution first. Weeks spoke to reporters after a brief hearing at which a defense lawyer said Mangione will fight extradition. The defense asked for a hearing on the issue. In the meantime, Mangione will be detained at a state prison in western Pennsylvania. Manhattan District Attorney Alvin Bragg’s office said Tuesday it will seek a Governor’s warrant to secure Mangione’s extradition to Manhattan. Under state law, New York Gov. Kathy Hochul can issue a warrant of arrest demanding Mangione’s return to the state. Such a warrant must recite the facts necessary to the validity of its issuance and be sealed with the state seal. It would then be presented to law enforcement in Pennsylvania to expedite Mangione’s return to New York. But Blair County District Attorney Peter Weeks says it won’t be a substantial barrier to returning Mangione to New York. He noted that defendants contest extradition “all the time,” including in simple retail theft cases. Dickey, his defense lawyer, questioned whether the second-degree murder charge filed in New York might be eligible for bail under Pennsylvania law, but prosecutors raised concerns about both public safety and Mangione being a potential flight risk, and the judge denied it. Mangione will continue to be housed at a state prison in Huntingdon. He has 14 days to challenge the detention. Prosecutors, meanwhile, have a month to seek a governor’s warrant out of New York. Mangione, wearing an orange jumpsuit, mostly stared straight ahead at the hearing, occasionally consulting papers, rocking in his chair, or looking back at the gallery. At one point, he began to speak to respond to the court discussion, but was quieted by his lawyer. Luigi Mangione, 26, has also been denied bail at a brief court hearing in western Pennsylvania. He has 14 days to challenge the bail decision. Story continues below video That’s with some intervention from owner Elon Musk. The account, which hasn’t posted since June, was briefly suspended by X. But after a user inquired about it in a post Monday, Musk responded “This happened without my knowledge. Looking into it.” The account was later reinstated. Other social media companies such as Meta have removed his accounts. According to X rules, the platform removes “any accounts maintained by individual perpetrators of terrorist, violent extremist, or mass violent attacks, as well as any accounts glorifying the perpetrator(s), or dedicated to sharing manifestos and/or third party links where related content is hosted.” Mangione is not accused of perpetrating a terrorist or mass attack — he has been charged with murder — and his account doesn’t appear to share any writings about the case. He shouted something that was partly unintelligible, but referred to an “insult to the intelligence of the American people.” He’s there for an arraignment on local charges stemming from his arrest Monday. He was dressed in an orange jumpsuit as officers led him from a vehicle into the courthouse. Local defense lawyer Thomas Dickey is expected to represent the 26-year-old at a Tuesday afternoon hearing at the Blair County Courthouse. Dickey declined comment before the hearing. Mangione could have the Pennsylvania charges read aloud to him and may be asked to enter a plea. They include possession of an unlicensed firearm, forgery and providing false identification to police. In New York, he was charged late Monday with murder in the death of UnitedHealthcare’s CEO Brian Thompson. Mangione likely was motivated by his anger with what he called “parasitic” health insurance companies and a disdain with corporate greed, said a a law enforcement bulletin obtained by The Associated Press. He wrote that the U.S. has the most expensive healthcare system in the world and that the profits of major corporations continue to rise while “our life expectancy” does not, according to the bulletin, based on a review of the suspect’s hand-written notes and social media postings. He appeared to view the targeted killing of the UnitedHealthcare CEO as a symbolic takedown, asserting in his note that he is the “first to face it with such brutal honesty,” the bulletin said. Mangione called “Unabomber” Ted Kaczynski a “political revolutionary” and may have found inspiration from the man who carried out a series of bombings while railing against modern society and technology, the document said. A felony warrant filed in New York cites Altoona Officer Christy Wasser as saying she found the writings along with a semi-automatic pistol and an apparent silencer. The filing echoes earlier statements from NYPD Chief of Detectives Joseph Kenny who said Mangione had a three-page, handwritten document that shows “some ill will toward corporate America.” Mangione is now charged in Pennsylvania with being a fugitive of justice. A customer at the McDonald’s in Altoona, Pennsylvania, where Mangione was arrested said one of his friends had commented beforehand that the man looked like the suspect wanted for the shooting in New York City. “It started out almost a little bit like a joke, my one friend thought he looked like the shooter,” said the customer, who declined to give his full name, on Tuesday. “It wasn’t really a joke, but we laughed about it,” he added. The warrant on murder and other charges is a step that could help expedite his extradition from Pennsylvania. In court papers made public Tuesday, a New York City police detective reiterated key findings in the investigation he said tied Mangione to the killing, including surveillance footage and a fake ID he used to check into a Manhattan hostel on Nov. 24. Police officers in Altoona, Pennsylvania, found that ID when they arrested Mangione on Monday. Mangione is being held without bail in Pennsylvania on charges of possession of an unlicensed firearm, forgery and providing false identification to police. Late Monday, Manhattan prosecutors charged him with five counts, including murder, criminal possession of a weapon and criminal possession of a forged instrument. Mangione doesn’t yet have a lawyer who can speak on his behalf, court officials said. Images of Mangione released Tuesday by Pennsylvania State Police showed him pulling down his mask in the corner of the McDonald’s while holding what appeared to be hash browns and wearing a winter jacket and ski cap. In another photo from a holding cell, he stood unsmiling with rumpled hair. Mangione’s cousin, Maryland lawmaker Nino Mangione, announced Tuesday morning that he’s postponing a fundraiser planned later this week at the Hayfields Country Club north of Baltimore, which was purchased by the Mangione family in 1986. “Because of the nature of this terrible situation involving my Cousin I do not believe it is appropriate to hold my fundraising event scheduled for this Thursday at Hayfields,” Nino Mangione said in a social media post. “I want to thank you for your thoughts, prayers, and support. My family and I are heartbroken and ask that you remember the family of Mr. Thompson in your prayers. Thank you.” Officers used New York City’s muscular surveillance system . Investigators analyzed DNA samples, fingerprints and internet addresses. Police went door to door looking for witnesses. When an arrest came five days later , those sprawling investigative efforts shared credit with an alert civilian’s instincts. A customer at a McDonald’s restaurant in Pennsylvania noticed another patron who resembled the man in the oblique security-camera photos New York police had publicized. He remains jailed in Pennsylvania, where he was initially charged with possession of an unlicensed firearm, forgery and providing false identification to police. By late Monday evening, prosecutors in Manhattan had added a charge of murder, according to an online court docket. It’s unclear whether Luigi Nicholas Mangione has an attorney who can comment on the allegations. Asked at Monday’s arraignment whether he needed a public defender, Mangione asked whether he could “answer that at a future date.”Saquon Barkley eclipses 2,000 rushing yards, joins elite company as Eagles clinch NFC East titleSANTA CLARA, Calif. (AP) — San Francisco 49ers quarterback Brock Purdy will miss Sunday's game against the Green Bay Packers with a sore throwing shoulder. Purdy injured his right shoulder in last Sunday's loss to the Seattle Seahawks . Purdy underwent an MRI that showed no structural damage but the shoulder didn't improve during the week and Purdy was ruled out for the game. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.